Get the Stockscreener App
2.00
6.98%
-0.15
After Hours:
2.01
0.010
+0.50%
Inovio Pharmaceuticals Inc stock is traded at $2.00, with a volume of 3.40M.
It is down -6.98% in the last 24 hours and down -22.18% over the past month.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
See More
Previous Close:
$2.15
Open:
$2
24h Volume:
3.40M
Relative Volume:
2.05
Market Cap:
$106.29M
Revenue:
$832.00K
Net Income/Loss:
$-135.12M
P/E Ratio:
-0.3284
EPS:
-6.09
Net Cash Flow:
$-124.69M
1W Performance:
-17.70%
1M Performance:
-22.18%
6M Performance:
+11.11%
1Y Performance:
-62.55%
1-Day Range:
$1.90
$2.045
1-Week Range:
$1.90
$2.44
52-Week Range:
$1.30
$5.3981
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Name
Inovio Pharmaceuticals Inc
Sector
Industry
Phone
(858) 410-3134
Address
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
2.00 | 114.26M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.22 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
674.55 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.95 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.64 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.69 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Piper Sandler | Overweight |
| May-14-24 | Initiated | Stephens | Overweight |
| Jan-25-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-09-22 | Downgrade | Maxim Group | Buy → Hold |
| Nov-01-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-19-22 | Resumed | RBC Capital Mkts | Sector Perform |
| May-11-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-29-21 | Resumed | Jefferies | Hold |
| Sep-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-24-21 | Initiated | Jefferies | Hold |
| Mar-23-21 | Initiated | BofA Securities | Neutral |
| Feb-12-21 | Initiated | Oppenheimer | Outperform |
| Nov-17-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Nov-10-20 | Upgrade | ROTH Capital | Sell → Neutral |
| Sep-28-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-28-20 | Upgrade | Maxim Group | Hold → Buy |
| Jul-01-20 | Downgrade | Maxim Group | Buy → Hold |
| Jul-01-20 | Downgrade | ROTH Capital | Neutral → Sell |
| Jun-29-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-26-20 | Downgrade | Stifel | Buy → Hold |
| May-21-20 | Initiated | The Benchmark Company | Buy |
| Apr-30-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Mar-13-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-13-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-19-19 | Initiated | ROTH Capital | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
| Oct-18-17 | Initiated | RBC Capital Mkts | Outperform |
| Sep-06-17 | Initiated | Citigroup | Buy |
| Jun-08-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-24-17 | Reiterated | Maxim Group | Buy |
| Mar-16-17 | Upgrade | Maxim Group | Hold → Buy |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
View All
Inovio Pharmaceuticals Inc Stock (INO) Latest News
Inovio Pharmaceuticals drops 6%, proposes equity offering - MSN
What is the fair value estimate for Inovio Pharmaceuticals Inc. (GBM) stock in 2025July 2025 Trade Ideas & Capital Efficient Trading Techniques - newser.com
Inovio outlines mid-2026 launch for INO-3107 as BLA submission progresses - MSN
Inovio plans public offering to fund DNA medicine development - The Pharma Letter
INOVIO Shares Drop 10% After Discounted $25 Million Public Offering - MSN
Inovio (INO) Prices Public Offering at $1.90 Per Share - GuruFocus
Inovio prices $25 million public offering of common stock By Investing.com - Investing.com Canada
Inovio Pharma falls on $25 mln stock sale - TradingView
INOVIO Pharmaceuticals (INO) Prices Public Offering at $1.90 Per Share - GuruFocus
Inovio prices $25 million public offering of common stock - Investing.com India
INOVIO stock falls after pricing $25 million public offering at discount - Investing.com UK
INOVIO stock falls after pricing $25 million public offering at discount By Investing.com - Investing.com South Africa
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2025 Earnings Call Transcript - Insider Monkey
INOVIO (NASDAQ: INO) prices 13,158,000-share common stock offering; gross $25M - Stock Titan
Can Inovio Pharmaceuticals Inc. stock outperform in 2025 bull marketBuy Signal & Fast Gain Swing Alerts - newser.com
Strategies to average down on Inovio Pharmaceuticals Inc.2025 Dividend Review & Community Shared Stock Ideas - newser.com
Is Inovio Pharmaceuticals Inc. trending in predictive chart modelsGold Moves & Technical Pattern Recognition Alerts - newser.com
Will Inovio Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Inovio Pharmaceuticals Plans to Launch Common Stock Offering - MarketScreener
INOVIO Announces Proposed Public Offering - lelezard.com
Inovio Pharmaceuticals (INO) Announces Public Stock Offering - GuruFocus
Analyzing Inovio Pharmaceuticals Inc. with multi timeframe charts2025 Market Sentiment & Community Driven Trade Alerts - newser.com
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Inovio Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat
Inovio Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks
Earnings call transcript: Inovio Q3 2025 focuses on innovation amid losses - Investing.com Philippines
Inovio Pharmaceuticals (INO) Achieves Key Milestone with BLA Sub - GuruFocus
INOVIO PHARMACEUTICALS INC (INO.MX) Q3 FY2025 earnings call transcript - Yahoo Finance
Transcript : Inovio Pharmaceuticals, Inc., Q3 2025 Earnings Call, Nov 10, 2025 - MarketScreener
Inovio Faces Losses But Analysts Remain Optimistic - Finimize
INOVIO announces common stock offering, shares details pending By Investing.com - Investing.com Canada
Inovio announces proposed public offering - MarketScreener
INOVIO (NASDAQ: INO) proposes common stock offering; 30-day 15% option included - Stock Titan
Oropharyngeal Cancer Market to Register Steady CAGR Throughout Forecast Period (2025-2034) Amid Shifting Treatment Paradigms | DelveInsight - Yahoo Finance
Inovio (INO) Anticipates Approval for INO-3107 and Advances DNA Medicines - GuruFocus
Inovio Q3 net loss widens on non-cash warrant liabilities - MarketScreener
Inovio: Q3 Earnings Snapshot - San Francisco Chronicle
Inovio Pharmaceuticals, Inc. (INO) Q3 FY2025 earnings call transcript - Yahoo Finance
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
INOVIO Grants Equity Award to New Hire Under 2022 Inducement Plan - MSN
Why Inovio Pharmaceuticals Inc. stock is a value investor pickMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock surprise markets with earningsMarket Trend Report & Fast Momentum Stock Entry Tips - newser.com
Can Inovio Pharmaceuticals Inc. (GBM) stock expand revenue streamsSell Signal & Accurate Technical Buy Alerts - newser.com
How to read the order book for Inovio Pharmaceuticals Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Inovio Pharmaceuticals Q3 2025 Earnings Preview - MSN
What hedge fund moves indicate for Inovio Pharmaceuticals Inc. (GBM) stockJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
How to use a screener to detect Inovio Pharmaceuticals Inc. breakoutsWeekly Market Summary & Expert Approved Momentum Ideas - newser.com
Inovio Pharmaceuticals (INO) Q3 Earnings Preview: What to Expect - GuruFocus
Will breakout in Inovio Pharmaceuticals Inc. lead to full recoveryJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Is Inovio Pharmaceuticals Inc. stock attractive after correctionJuly 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Inovio Shares Face Critical Week Amid Conflicting Signals - AD HOC NEWS
Inovio Pharmaceuticals Inc Stock (INO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):